Scotts Miracle-Gro
Scotts Miracle-Gro's revenue fell 3.9% to $3.4 billion in fiscal 2025. Its operating margin was 10.5%, up from 5.9% a year earlier. Free cash flow was $274 million, down 53.1%. It paid out $173 million in dividends and buybacks, 63% of free cash flow. The diluted share count rose 3.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share fell 7.7% a year and net income 8.3% a year, while buybacks cut the share count by 5%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Scotts Miracle-Gro yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Scotts Miracle-Gro's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Scotts Miracle-Gro's fiscal 2025 free cash flow of $274M, net cash of −$2.1B at September 30, 2025 and 59 million diluted shares, from its filings. The scenarios are fitted to Scotts Miracle-Gro: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -4.5% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 13%: 11% for a cyclical or higher-risk business (Fertilizers & Agricultural Chemicals), plus 1 point as a smaller company, worth $3.5B, plus 1 point for unsteady results (a loss in fiscal 2024); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target. A negative value means Scotts Miracle-Gro's net debt is larger than what that scenario's cash flows are worth today.
- Last close, October 26, 2026
- $58.83
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Scotts Miracle-Gro's earnings per share of $1.18 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 20.2×, the middle of Scotts Miracle-Gro's own P/E today, its peers' median and its sector's median (the Materials median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 14%, 13% and 12%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $58.83
- Value at this multiple, against the last close
- —
- Scotts Miracle-Gro's P/E at the last close
- 49.9×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Scotts Miracle-GroSMG | $58.83 | $1.18 | 49.9× |
| CF IndustriesCF | $120.84 | $13.48 | 9.0× |
| CortevaCTVA | $11.95 | $1.52 | 7.9× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 244 | 87 | 32 | 72 | 37 |
| Debt incl. finance leases | 2,315 | 2,992 | 2,631 | 2,243 | 2,120 |
| Net debt (negative means net cash) | 2,071 | 2,905 | 2,599 | 2,171 | 2,083 |
| Net debt to EBITDA | 2.5x | — | — | 7.5x | 4.8x |
| Debt to equity | 2.3x | — | — | — | — |
| Interest coverage | 9.2x | −3.7x | −1.0x | 1.3x | 2.8x |
| Current ratio | 1.8x | 2.1x | 1.8x | 1.3x | 1.3x |
| Quick ratio | 0.8x | 0.7x | 0.7x | 0.5x | 0.5x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $49,508 of Scotts Miracle-Gro shares on the open market, and 3 insiders sold $5.5 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Mark D KingdonDirector | Sold | 831 | $61.65 | $51,231 | Form 4 |
| Aug 3, 2026 | Hagedorn Partnership L.P.Director, 10% owner | Sold | 30,000 | $67.45 | $2.0 million | Form 4 |
| Jul 30, 2026 | Stephen L JohnsonDirector | Sold | 1,171 | $68.32 | $80,000 | Form 4 |
| Feb 24, 2026 | Mark J ScheiwerEVP, CFO & CAO | Bought | 693 | $71.44 | $49,508 | Form 4 |
| Feb 12, 2026 | Hagedorn Partnership L.P.Director, 10% owner | Sold | 50,000 | $66.40 | $3.3 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Fail | Fail | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 4 of 9 | 5 of 9 | 6 of 9 |
| Accruals ratio | −23.6% | −22.4% | −8.1% |
Compare
Put Scotts Miracle-Gro side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Scotts Miracle-Gro | FY25 | −3.9% | 10.5% | 8.0% | 13.4% | 4.8x | 6 | |
| FMC | FY25 | −18.3% | −47.0% | −3.0% | −19.6% | — | 2 | Compare |
| CF Industries | FY25 | 19.3% | 32.5% | 25.4% | 20.6% | 0.4x | 8 | Compare |
| Mosaic | FY25 | 8.4% | 6.8% | −4.4% | 2.5% | 2.5x | 8 | Compare |
| Corteva | FY25 | 2.9% | — | 16.2% | 5.8% | −0.6x | 8 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 2,506 | 2,642 | 2,663 | 3,156 | 4,132 | 4,925 | 3,924 | 3,551 | 3,553 | 3,413 |
| Revenue growth | −16.9% | 5.4% | 0.8% | 18.5% | 30.9% | 19.2% | −20.3% | −9.5% | 0.0% | −3.9% |
| Gross profit | 900 | 973 | 865 | 1,020 | 1,347 | 1,469 | 873 | 657 | 850 | 1,044 |
| Research and development | 36 | 40 | 42 | 40 | 40 | 45 | 45 | 36 | 35 | 35 |
| Operating income | 448 | 433 | 199 | 410 | 585 | 723 | −434 | −174 | 209 | 359 |
| Net income | 315 | 218 | 64 | 461 | 387 | 512 | −438 | −380 | −35 | 145 |
| Diluted EPS (US$) | 5.09 | 3.63 | 1.12 | 8.18 | 6.81 | 8.96 | −7.88 | −6.79 | −0.61 | 2.47 |
| Diluted shares (millions) | 62 | 60 | 57 | 56 | 57 | 57 | 56 | 56 | 57 | 59 |
| Cash flow | ||||||||||
| Cash from operations | 244 | 363 | 342 | 227 | 558 | 272 | −129 | 531 | 668 | 371 |
| Capital expenditure | 58 | 70 | 68 | 42 | 63 | 107 | 114 | 93 | 84 | 97 |
| Free cash flow | 186 | 294 | 274 | 184 | 495 | 165 | −242 | 438 | 584 | 274 |
| Dividends paid | 117 | 120 | 120 | 124 | 411 | 143 | 166 | 149 | 151 | 154 |
| Share buybacks | 137 | 255 | 328 | 3 | 53 | 129 | 258 | 9 | 5 | 18 |
| Acquisitions | 158 | 122 | 493 | 7 | 0 | 128 | 237 | 0 | 0 | 2 |
| Stock-based compensation | 16 | 25 | 40 | 38 | 58 | 41 | 34 | 69 | 80 | 69 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 29 | 120 | 34 | 19 | 17 | 244 | 87 | 32 | 72 | 37 |
| Debt incl. finance leases | 1,222 | 1,410 | 2,026 | 1,634 | 1,531 | 2,315 | 2,992 | 2,631 | 2,243 | 2,120 |
| Total assets | 2,756 | 2,747 | 3,054 | 3,029 | 3,380 | 4,800 | 4,297 | 3,414 | 2,872 | 2,742 |
| Total liabilities | 2,022 | 2,085 | 2,695 | 2,306 | 2,678 | 3,787 | 4,149 | 3,681 | 3,262 | 3,100 |
| Shareholders' equity | 715 | 649 | 355 | 719 | 697 | 1,013 | 148 | −267 | −391 | −358 |
| Margins and ratios | ||||||||||
| Gross margin | 35.9% | 36.8% | 32.5% | 32.3% | 32.6% | 29.8% | 22.2% | 18.5% | 23.9% | 30.6% |
| Operating margin | 17.9% | 16.4% | 7.5% | 13.0% | 14.2% | 14.7% | −11.1% | −4.9% | 5.9% | 10.5% |
| Net margin | 12.6% | 8.3% | 2.4% | 14.6% | 9.4% | 10.4% | −11.2% | −10.7% | −1.0% | 4.2% |
| Free cash flow margin | 7.4% | 11.1% | 10.3% | 5.8% | 12.0% | 3.3% | −6.2% | 12.3% | 16.4% | 8.0% |
| Return on capital | 15.7% | 14.1% | 9.2% | 13.1% | 19.5% | 20.8% | −11.2% | −5.1% | 8.0% | 13.4% |
| Return on equity | 47.2% | 32.0% | 12.7% | 85.8% | 54.7% | 59.9% | −75.4% | — | — | — |
| Return on assets | 11.9% | 7.9% | 2.2% | 15.2% | 12.1% | 12.5% | −9.6% | −9.9% | −1.1% | 5.2% |
| Net debt to EBITDA | 2.3x | 2.5x | 7.1x | 3.2x | 2.2x | 2.5x | — | — | 7.5x | 4.8x |